(PDF) Paradoxical Decrease in HDL-cholesterol and

Paradoxical Decrease in HDL-cholesterol and Apolipoprotein A1 With Simvastatin and Atorvastatin in a Patient With Type 2 Diabetes

Annals of Clinical Biochemistry - United Kingdom

doi 10.1258/acb.2010.010081

Full Text

Abstract

Available in full text

Categories

Clinical Biochemistry

Date

November 29, 2010

Authors

S. Ramachandran

Publisher

SAGE Publications

Related search

Paradoxical Severe Decrease in Serum HDL-cholesterol After Treatment With a Fibrate

Journal of Clinical Pathology

Forensic Medicine

English

Pdb2 - Comparison of Atorvastatin and Simvastatin Effect on Glycated Hemoglobin Control Among Outpatients With Type 2 Diabetes Mellitus

Value in Health

Occupational Health

English

Paradoxical Glycaemic Response to Surgical Treatment of Ovarian Hyperthecosis in a Patient With Type 2 Diabetes

British Journal of Diabetes and Vascular Disease

Internal Medicine

Cardiovascular Medicine

English

Atorvastatin and Micronized Fenofibrate Alone and in Combination in Type 2 Diabetes With Combined Hyperlipidemia

Internal Medicine

Specialized Nursing

English

Triglyceride-To-HDL Cholesterol Ratio in the Dyslipidemic Classification of Type 2 Diabetes

Internal Medicine

Specialized Nursing

English

The HDL Cholesterol/Apolipoprotein A-I Ratio

Current Opinion in Endocrinology, Diabetes and Obesity

Internal Medicine

English

HDL-apolipoprotein A-I Exchange Is Independently Associated With Cholesterol Efflux Capacity

Journal of Lipid Research

English

Glycemic Assessment in a Patient With HB Leiden and Type 2 Diabetes

AACE Clinical Case Reports

English

Changes of Total Cholesterol, HDL-cholesterol, Apolipoprotein A-I and A-Ii in School Boys and Girls

The Journal of Japan Atherosclerosis Society

English